OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advanced RAI-refractory thyroid cancer: an update on treatment perspectives
Olga Karapanou, George Simeakis, Barbara Vlassopoulou, et al.
Endocrine Related Cancer (2022) Vol. 29, Iss. 5, pp. R57-R66
Open Access | Times Cited: 24
Olga Karapanou, George Simeakis, Barbara Vlassopoulou, et al.
Endocrine Related Cancer (2022) Vol. 29, Iss. 5, pp. R57-R66
Open Access | Times Cited: 24
Showing 24 citing articles:
Molecular features of aggressive thyroid cancer
Giusy Elia, Armando Patrizio, Francesca Ragusa, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
Giusy Elia, Armando Patrizio, Francesca Ragusa, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
Clinical and Histopathological Risk Factors for Radioactive Iodine–Refractory Follicular and Oncocytic Thyroid Carcinoma
Merel T Stegenga, Evert F.S. van Velsen, Lindsey Oudijk, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2334-e2341
Open Access | Times Cited: 5
Merel T Stegenga, Evert F.S. van Velsen, Lindsey Oudijk, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2334-e2341
Open Access | Times Cited: 5
Management of Progressive Radioiodine-Refractory Thyroid Carcinoma: Current Perspective
Alice Nervo, Francesca Retta, Alberto Ragni, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 3047-3062
Open Access | Times Cited: 12
Alice Nervo, Francesca Retta, Alberto Ragni, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 3047-3062
Open Access | Times Cited: 12
Preclinical Models of Follicular Cell-Derived Thyroid Cancer: An Overview from Cancer Cell Lines to Mouse Models
Min Ji Jeon, Bryan R. Haugen
Endocrinology and Metabolism (2022) Vol. 37, Iss. 6, pp. 830-838
Open Access | Times Cited: 10
Min Ji Jeon, Bryan R. Haugen
Endocrinology and Metabolism (2022) Vol. 37, Iss. 6, pp. 830-838
Open Access | Times Cited: 10
Efficacy and safety of targeted therapeutics for patients with radioiodine-refractory differentiated thyroid cancer: Systematic review and network meta-analysis
Xiaoyu Ji, Weili Liang, Guixu Lv, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Xiaoyu Ji, Weili Liang, Guixu Lv, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Clinicopathological features of differentiated thyroid carcinoma as predictors of the effects of radioactive iodine therapy
Wen Liu, Beibei Jiang, Jingli Xue, et al.
Annals of Diagnostic Pathology (2023) Vol. 69, pp. 152243-152243
Closed Access | Times Cited: 4
Wen Liu, Beibei Jiang, Jingli Xue, et al.
Annals of Diagnostic Pathology (2023) Vol. 69, pp. 152243-152243
Closed Access | Times Cited: 4
MYB/LINC00092 regulatory axis promotes the progression of papillary thyroid carcinoma
Lian Cheng, Xian Deng, Le Yuan
Endokrynologia Polska (2024) Vol. 75, Iss. 1, pp. 27-34
Open Access | Times Cited: 1
Lian Cheng, Xian Deng, Le Yuan
Endokrynologia Polska (2024) Vol. 75, Iss. 1, pp. 27-34
Open Access | Times Cited: 1
Efficacy and Safety of Multikinase Inhibitors for Patients With Refractory Thyroid Cancer: Systematic Review and Network Meta-Analysis
Jing Ren, Nan Wu, Yang Wu, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 1
Jing Ren, Nan Wu, Yang Wu, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 1
Research trends and hotspots of radioiodine-refractory thyroid cancer treatment in the twenty-first century: a bibliometric analysis
Yuhang Xue, Yuzhe Zhang, Xintao Ding, et al.
Annals of Nuclear Medicine (2024)
Open Access | Times Cited: 1
Yuhang Xue, Yuzhe Zhang, Xintao Ding, et al.
Annals of Nuclear Medicine (2024)
Open Access | Times Cited: 1
Pathogenesis and Management Strategies in Radioiodine-Refractory Differentiated Thyroid Cancer: From Molecular Mechanisms Toward Therapeutic Approaches: A Comprehensive Review
Iulia-Alexandra Voinea, Eugenia Petrova, Nicoleta Dumitru, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7161-7161
Open Access | Times Cited: 1
Iulia-Alexandra Voinea, Eugenia Petrova, Nicoleta Dumitru, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7161-7161
Open Access | Times Cited: 1
Approach to Hyperthyroidism
Raisa Chowdhury, Sena Turkdogan, Jennifer A. Silver, et al.
Journal of Otorhinolaryngology Hearing and Balance Medicine (2024) Vol. 5, Iss. 2, pp. 20-20
Open Access | Times Cited: 1
Raisa Chowdhury, Sena Turkdogan, Jennifer A. Silver, et al.
Journal of Otorhinolaryngology Hearing and Balance Medicine (2024) Vol. 5, Iss. 2, pp. 20-20
Open Access | Times Cited: 1
Plasma exchange as a rescue therapy for treatment-resistant thyroid storm with concurrent heart failure: a literature review based on a case report
Pouya Ebrahimi, Moloud Payab, Maryam Taheri, et al.
International Journal of Emergency Medicine (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Pouya Ebrahimi, Moloud Payab, Maryam Taheri, et al.
International Journal of Emergency Medicine (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Adherens Junction Integrity Is a Critical Determinant of Sodium Iodide Symporter Residency at the Plasma Membrane of Thyroid Cells
Márcia Faria, José Vareda, Micaella Miranda, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5362-5362
Open Access | Times Cited: 6
Márcia Faria, José Vareda, Micaella Miranda, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5362-5362
Open Access | Times Cited: 6
Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial
Maaike Dotinga, Dennis Vriens, Floris H. P. van Velden, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3154-3154
Open Access | Times Cited: 6
Maaike Dotinga, Dennis Vriens, Floris H. P. van Velden, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3154-3154
Open Access | Times Cited: 6
Analysis of the key ligand receptor CADM1_CADM1 in the regulation of thyroid cancer based on scRNA-seq and bulk RNA-seq data
Hui He, Shan Cong, Yu Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 4
Hui He, Shan Cong, Yu Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 4
Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer
Jing Li, Yingjie Zhang, Fenghao Sun, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 3
Jing Li, Yingjie Zhang, Fenghao Sun, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 3
Illustrative Review of Nuclear Medicine Thyroid Studies
Stephanie M. Walker, Andrew Schneider, Olumide A. Olulade, et al.
Radiographics (2024) Vol. 44, Iss. 2
Closed Access
Stephanie M. Walker, Andrew Schneider, Olumide A. Olulade, et al.
Radiographics (2024) Vol. 44, Iss. 2
Closed Access
Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma
M. Bel Lakhdar, A. Mouaden, M. Zekri, et al.
World Journal of Nuclear Medicine (2024) Vol. 23, Iss. 03, pp. 185-190
Open Access
M. Bel Lakhdar, A. Mouaden, M. Zekri, et al.
World Journal of Nuclear Medicine (2024) Vol. 23, Iss. 03, pp. 185-190
Open Access
No Correlation between PD-L1 and NIS Expression in Lymph Node Metastatic Papillary Thyroid Carcinoma
Bernadett Lévay, Kiss Alexandra, Georgina Fröhlich, et al.
Diagnostics (2024) Vol. 14, Iss. 17, pp. 1858-1858
Open Access
Bernadett Lévay, Kiss Alexandra, Georgina Fröhlich, et al.
Diagnostics (2024) Vol. 14, Iss. 17, pp. 1858-1858
Open Access
Elucidating the Prognostic Role of BRAF V600E and the Activation Status of the Downstream MAPK Pathway in PTC: A Study from a Tertiary Centre in India
Nadeem Kocheri, Priti Chatterjee, Shipra Agarwal, et al.
Indian Journal of Endocrinology and Metabolism (2024) Vol. 28, Iss. 6, pp. 617-621
Open Access
Nadeem Kocheri, Priti Chatterjee, Shipra Agarwal, et al.
Indian Journal of Endocrinology and Metabolism (2024) Vol. 28, Iss. 6, pp. 617-621
Open Access
Changes in peripheral blood immune cell population in thyroid cancer patients treated with lenvatinib
Meihua Jin, Chae A. Kim, Dong Jun Bae, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Meihua Jin, Chae A. Kim, Dong Jun Bae, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
The Study of lnc RNA BANCR Expression and TSHR Methylation in BRAFV600E Mutated PTC
波 于
World Journal of Cancer Research (2024) Vol. 14, Iss. 01, pp. 13-19
Closed Access
波 于
World Journal of Cancer Research (2024) Vol. 14, Iss. 01, pp. 13-19
Closed Access
Update on iodine-refractory differentiated thyroid carcinoma
Estephany Abou Jokh Casas, Alessandra Repetto, Alba Rodríguez Gasén, et al.
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) (2023) Vol. 42, Iss. 5, pp. 325-334
Closed Access
Estephany Abou Jokh Casas, Alessandra Repetto, Alba Rodríguez Gasén, et al.
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) (2023) Vol. 42, Iss. 5, pp. 325-334
Closed Access
Actualización en carcinoma diferenciado de tiroides refractario a radioyodo
Estephany Abou Jokh Casas, Alessandra Repetto, Alba Rodríguez Gasén, et al.
Revista Española de Medicina Nuclear e Imagen Molecular (2023) Vol. 42, Iss. 5, pp. 324-333
Closed Access
Estephany Abou Jokh Casas, Alessandra Repetto, Alba Rodríguez Gasén, et al.
Revista Española de Medicina Nuclear e Imagen Molecular (2023) Vol. 42, Iss. 5, pp. 324-333
Closed Access
